Pasc post acute sequelae of covid 19 Clinical Trials
Conditions / Pasc post acute sequelae of covid 19
Delta Trials records 9 clinical trials for Pasc post acute sequelae of covid 19 in its publicly accessible dataset. From the full dataset, 6 actively seeking eligible participants and 1 trial have reached completion. This research is conducted across 11 study locations around the world. An additional 2 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
9
Total Trials
6
Recruiting
1
Completed
2
Other Active
0
Terminated since 2020
11
Study Locations
Browse by location (11 total)
- San Francisco, United States 1 trialAll trials in San Francisco, United States
- Salt Lake City, United States 1 trialAll trials in Salt Lake City, United States
- Sacramento, United States 1 trialAll trials in Sacramento, United States
- Taipei, Taiwan 1 trialAll trials in Taipei, Taiwan
- Taipei, Taiwan 1 trialAll trials in Taipei, Taiwan
- Amsterdam, Netherlands 1 trialAll trials in Amsterdam, Netherlands
- New Taipei City, Taiwan 1 trialAll trials in New Taipei City, Taiwan
- New Taipei City, Taiwan 1 trialAll trials in New Taipei City, Taiwan
- Bethesda, United States 1 trialAll trials in Bethesda, United States
- Baltimore, United States 1 trialAll trials in Baltimore, United States
- Boston, United States 1 trialAll trials in Boston, United States
- Albuquerque, United States 1 trialAll trials in Albuquerque, United States
- Los Angeles, United States 1 trialAll trials in Los Angeles, United States